The Inhibition of Biotransformation Enzymes Affects the Response of PC3 Prostate Cancer Cell Line to Docetaxel

Objectives: Targeting drug-metabolizing enzymes in tumor cells may improve chemoprevention and chemotherapy by providing new targets for anticancer agents or combination therapies. This study investigated whether inhibition of CYP1A1, CYP3A4, and GSTP1 by α-naphthoflavone, ketoconazole, and quercetin modulates docetaxel activity in PC3 prostate cancer cells and PNT1A prostate epithelial cells. Materials and Methods: PC3 and PNT1A cells were exposed to docetaxel either alone or in combination with inhibitors of CYP1A1, CYP3A4, and GSTP1. Sub-lethal monotherapy doses were calibrated to produce approximately 70% cell viability at 24 hours and 60% at 48 hours. Cell viability was assessed by WST-1 assay, while apoptosis and necrosis were evaluated using Annexin V staining. Enzyme activities were measured by ELSA. Cellular oxidative activity was assessed by DCFDA fluorescence analysis. Results: In PC3 cells, calibrated monotherapy doses were: 4 µM docetaxel, 1000 nM α-naphthoflavone, 56.5 µM ketoconazole, and 300 µM quercetin. Combination treatments reduced cell viability by an additional 12-25% at 24 hours and by up to 45% at 48 hours, compared with docetaxel alone. Docetaxel treatment induced time-dependent changes in enzyme activities, whereas combination treatments markedly reduced DCFDA fluorescence signals. Conclusion: Co-administration of docetaxel with CYP1A1, CYP3A4, and GSTP1-related pharmacological modulators may enhance cytotoxicity in prostate cancer cells. Increased cytotoxicity was accompanied by reduced DCFDA fluorescence, indicating that enhanced treatment responses were not necessarily associated with increased oxidative fluorescence signals.

Authors

Institutions

Publication Details

Journal
Turkish Journal of Pharmaceutical Sciences
Published
2026-11-16
DOI
https://doi.org/10.4274/tjps.galenos.2026.67927
Primary Topic
Pharmacogenetics and Drug Metabolism
Type
article
Field-Weighted Citation Impact
0.00

Funders

Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
NOV
article

The Inhibition of Biotransformation Enzymes Affects the Response of PC3 Prostate Cancer Cell Line to Docetaxel

Dilek Telci, İpek Bedir, Nülüfer Tülün Güray, Derya DİLEK KANÇAĞI
1 links
Turkish Journal of Pharmaceutical Sciences
Pharmacogenetics and Drug Metabolism
article

The Inhibition of Biotransformation Enzymes Affects the Response of PC3 Prostate Cancer Cell Line to Docetaxel

Dilek Telci, İpek Bedir, Nülüfer Tülün Güray, Derya DİLEK KANÇAĞI
article en

Abstract

Objectives: Targeting drug-metabolizing enzymes in tumor cells may improve chemoprevention and chemotherapy by providing new targets for anticancer agents or combination therapies. This study investigated whether inhibition of CYP1A1, CYP3A4, and GSTP1 by α-naphthoflavone, ketoconazole, and quercetin modulates docetaxel activity in PC3 prostate cancer cells and PNT1A prostate epithelial cells. Materials and Methods: PC3 and PNT1A cells were exposed to docetaxel either alone or in combination with inhibitors of CYP1A1, CYP3A4, and GSTP1. Sub-lethal monotherapy doses were calibrated to produce approximately 70% cell viability at 24 hours and 60% at 48 hours. Cell viability was assessed by WST-1 assay, while apoptosis and necrosis were evaluated using Annexin V staining. Enzyme activities were measured by ELSA. Cellular oxidative activity was assessed by DCFDA fluorescence analysis. Results: In PC3 cells, calibrated monotherapy doses were: 4 µM docetaxel, 1000 nM α-naphthoflavone, 56.5 µM ketoconazole, and 300 µM quercetin. Combination treatments reduced cell viability by an additional 12-25% at 24 hours and by up to 45% at 48 hours, compared with docetaxel alone. Docetaxel treatment induced time-dependent changes in enzyme activities, whereas combination treatments markedly reduced DCFDA fluorescence signals. Conclusion: Co-administration of docetaxel with CYP1A1, CYP3A4, and GSTP1-related pharmacological modulators may enhance cytotoxicity in prostate cancer cells. Increased cytotoxicity was accompanied by reduced DCFDA fluorescence, indicating that enhanced treatment responses were not necessarily associated with increased oxidative fluorescence signals.

Turkish Journal of Pharmaceutical Sciences
Yeditepe University (TR), Middle East Technical University (TR), Fenerbahçe University (TR)
Yeditepe Üniversitesi
Good health and well-being
Pharmacogenetics and Drug Metabolism
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

Laika access coming soon